Full Text View
Tabular View
No Study Results Posted
Related Studies
Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
This study is currently recruiting participants.
Study NCT00065260   Information provided by National Institutes of Health Clinical Center (CC)
First Received: July 18, 2003   Last Updated: September 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aplastic Anemia
Additional conditions recognized in this trial
Anemia
Anemia, Aplastic
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Interventions listed in this trial
Alemtuzumab (Campath-1H)
Thymoglobulin (r-ATG)
Cyclosporine (CsA)
Additional drug interventions recognized in this trial
Alemtuzumab
Antilymphocyte Serum
Cyclosporine
Cyclosporins
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antineoplastic Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services